1. Home
  2. PT vs CING Comparison

PT vs CING Comparison

Compare PT & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PT
  • CING
  • Stock Information
  • Founded
  • PT 2012
  • CING 2012
  • Country
  • PT China
  • CING United States
  • Employees
  • PT N/A
  • CING N/A
  • Industry
  • PT Computer Software: Programming Data Processing
  • CING Biotechnology: Pharmaceutical Preparations
  • Sector
  • PT Technology
  • CING Health Care
  • Exchange
  • PT Nasdaq
  • CING Nasdaq
  • Market Cap
  • PT 15.2M
  • CING 16.2M
  • IPO Year
  • PT 2018
  • CING 2021
  • Fundamental
  • Price
  • PT $0.95
  • CING $4.25
  • Analyst Decision
  • PT
  • CING Strong Buy
  • Analyst Count
  • PT 0
  • CING 4
  • Target Price
  • PT N/A
  • CING $30.67
  • AVG Volume (30 Days)
  • PT 12.6K
  • CING 106.4K
  • Earning Date
  • PT 07-15-2025
  • CING 08-12-2025
  • Dividend Yield
  • PT N/A
  • CING N/A
  • EPS Growth
  • PT N/A
  • CING N/A
  • EPS
  • PT N/A
  • CING N/A
  • Revenue
  • PT $4,814,566.00
  • CING N/A
  • Revenue This Year
  • PT N/A
  • CING N/A
  • Revenue Next Year
  • PT N/A
  • CING N/A
  • P/E Ratio
  • PT N/A
  • CING N/A
  • Revenue Growth
  • PT N/A
  • CING N/A
  • 52 Week Low
  • PT $0.76
  • CING $1.80
  • 52 Week High
  • PT $1.15
  • CING $20.83
  • Technical
  • Relative Strength Index (RSI)
  • PT 60.01
  • CING 53.17
  • Support Level
  • PT $0.89
  • CING $3.97
  • Resistance Level
  • PT $0.95
  • CING $4.26
  • Average True Range (ATR)
  • PT 0.06
  • CING 0.27
  • MACD
  • PT 0.01
  • CING -0.01
  • Stochastic Oscillator
  • PT 100.00
  • CING 48.10

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees, as well as by providing financing for these borrowers and earning installment service fees. The company earns wealth management services fees and commissions on financial products. The company generates the majority of its revenue from Wealth management service fees and others.

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: